Jeongpung Korea Pharm, Co., Ltd.
⚠️ Moderate Risk
FEI: 3003802464 • Chunbuk • SOUTH KOREA
FEI Number
3003802464
Location
Chunbuk
Country
SOUTH KOREAAddress
11-1 Shindong-Ri, Maegdong-Hyun, , Chunbuk, , South Korea
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 6/5/2003 | 66VBH99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Los Angeles District Office (LOS-DO) |
| 6/5/2003 | 66VBL99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Los Angeles District Office (LOS-DO) |
| 6/5/2003 | 66VBE99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Los Angeles District Office (LOS-DO) |
| 6/5/2003 | 66VBL99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Los Angeles District Office (LOS-DO) |
Frequently Asked Questions
What is Jeongpung Korea Pharm, Co., Ltd.'s FDA import refusal history?
Jeongpung Korea Pharm, Co., Ltd. (FEI: 3003802464) has 4 FDA import refusal record(s) in our database, spanning from 6/5/2003 to 6/5/2003.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Jeongpung Korea Pharm, Co., Ltd.'s FEI number is 3003802464.
What types of violations has Jeongpung Korea Pharm, Co., Ltd. received?
Jeongpung Korea Pharm, Co., Ltd. has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Jeongpung Korea Pharm, Co., Ltd. come from?
All FDA import refusal data for Jeongpung Korea Pharm, Co., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.